Literature DB >> 11980518

Varicella vaccine and shingles.

Marc Brisson, W John Edmunds, Nigel J Gay, Elizabeth Miller.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 11980518     DOI: 10.1001/jama.287.17.2211

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  Economic evaluation of varicella vaccination programmes: a review of the literature.

Authors:  Thomas Hammerschmidt; Kurt Banz; Stefan Wagenpfeil; Albrecht Neiss; Peter Wutzler
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerations.

Authors:  M J Postma; J M Bos; R Welte; R de Groot; W Luytjes; H C Rümke; P Beutels
Journal:  Eur J Health Econ       Date:  2004-02

3.  Should varicella vaccine be included in the routine immunization programme?

Authors:  Hualiang Lin; Yu Liu; Linwei Tian
Journal:  Transl Pediatr       Date:  2014-10

Review 4.  Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data.

Authors:  G S Goldman; P G King
Journal:  Vaccine       Date:  2012-06-01       Impact factor: 3.641

5.  Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--5.

Authors:  Richard Pitman; David Fisman; Gregory S Zaric; Maarten Postma; Mirjam Kretzschmar; John Edmunds; Marc Brisson
Journal:  Value Health       Date:  2012 Sep-Oct       Impact factor: 5.725

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.